Please login to the form below
Cardiovascular outcomes
This page shows the latest Cardiovascular outcomes news and features for those working in and with pharma, biotech and healthcare.
Roche partners with Alnylam on hypertension therapy in deal worth up to $2.8bn
Hypertension, the leading cause of cardiovascular disease, affects more than 1.2 billion adults worldwide. ... cardiovascular outcomes data in hand at launch to ensure results relevant not only for health authorities but also for access and clinical
Latest news
-
NewAmsterdam Pharma and Frazier LifeSciences announce merger agreement
The company believes the cash total will be sufficient to fund operations until 2026, beyond multiple phase 3 data read-outs for obicetrapib, including an ongoing cardiovascular outcomes trial. ... a global population of over 30 million patients with
-
UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients
primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke. ... In highlighting the lack of long-term evidence of the drug’s effect on cardiovascular outcomes, NICE also announced a
-
Bayer’s finerenone scores FDA priority review for chronic kidney disease
Overactivation of the mineralocorticoid receptor is believed to play a key role in kidney and cardiovascular damage, through inflammatory and fibrotic processes. ... The key secondary endpoint, which measures cardiovascular outcomes, found that the
-
Novo Nordisk launches late-stage study in Alzheimer’s disease
Also, in post-hoc analysis of data from three large cardiovascular outcomes trials conducted by Novo Nordisk, which included 15, 820 patients with type 2 diabetes and a median follow-up
-
Novartis scores CHMP backing for cholesterol drug Leqvio
in adults with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk equivalent and heterozygous familial hypercholesterolemia (HeFH). ... Another trial, dubbed ORION-4, is currently underway to determine if the reduction in LDL-C is coupled with an
More from news
Approximately 1 fully matching, plus 135 partially matching documents found.
Latest Intelligence
-
Cardiovascular disease: the impact of COVID-19 on patient outcomes
JoAnne Foody talks to PME about the role of statins in helping to prevent cardiovascular disease. ... PME: What is the role of statins and non-statins in improving long-term CVD outcomes?
-
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
Hyperkalaemia (elevated levels of potassium in the blood) and anaemia are both common complications of CKD, associated with poorer cardiovascular outcomes and an increased risk of hospitalisation and death. ... Joris Silon is Senior Vice President,
-
Treatment and prevention of cardiovascular disease
For individuals with diabetes, cardiovascular disease is the leading cause of morbidity and mortality. ... Against this backdrop, the ability to treat both type 2 diabetes by improving blood glucose control and substantially improve cardiovascular
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
Prof Sir Mike Richards joins Incisive Health as senior counsel
In July 2012 he was appointed as Director for Reducing Premature Mortality on the NHS Commissioning Board (now NHS England), where he led the development of a cardiovascular outcomes strategy. ... These are vital attributes if the NHS is to navigate the
-
Teva's Mark Salyer joins Amarin
Salyer’s appointment comes at a key juncture for Amarin as it awaits next year’s publication of results from the REDUCE-IT cardiovascular outcomes trial.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
World Heart Day 2020: It's time to make our clinical trials more inclusive
Disparities in cardiovascular health outcomes between different ethnic groups. Despite the progress that’s been made in treating heart disease, there is still a huge difference in mortality between white people ... Health outcomes are also related to
-
A new vision for tackling key illnesses
It also looks at other areas, such as cardiovascular and respiratory conditions, and explains how the NHS plans to change its approach in order to drive improvements in patient care and ... outcomes. Cardiovascular disease (CVD). Cardiovascular disease
-
Conference research case study
Our client had recently conducted a series of clinical trials with its breakthrough cardiovascular product, resulting in outcomes data which had the potential to give it a more competitive edge and ... Communication strategies and marketing messages were
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
